Warning. Research only: not approved by the FDA for any use in people. Information is for scientific awareness only. Not a recommendation to use, buy or compound.
No perspectives yet — be the first!
Be the first verified clinician to share how you read the research on GHK-Cu.
100% anonymous · NPI-verifiedFDA status last checked Nov 11, 2026
Found in human plasma; promotes proliferation of hepatoma cells, lymphocytes & mycoplsma; maintains viability of hepatocytes, eosinophils and macrophages; inhibits growth of glial cells.
GHK-Cu
Not approved for use in people. Mostly lab or animal research.
We have not yet attached proof for an evidence level.
There is no FDA-approved product with this peptide.
How it works. Proven facts and ideas still being studied are kept apart.
Not yet reviewed.
We have not yet attached proof for an evidence level.
Not FDA-approved. In FDA's 503A category 1 (under evaluation) for non-injectable use only, as of May 14, 2026. The injectable nomination was withdrawn.
Last verified: Nov 11, 2026
Scientific views only. No use in patients or dosing is discussed.
Share your scientific view of the published evidence on GHK-Cu.
Your view of the published research guides colleagues
Your name is never shown, only your specialty and region
About the published research. No use in patients or dosing
